文献速递产科母胎医学

ω-3补充剂对妊娠结局的影响:按吸烟状态分析

The effect of omega-3 supplementation on pregnancy outcomes by smoking status.
PubMed 文献 · Am J Obstet Gynecol · 2017-05-23

这项多中心随机对照试验的二次分析纳入851例有单胎自发性早产史的单胎妊娠妇女,评估ω-3补充对早产预防的效果是否因吸烟状态而异。结果显示,吸烟者中ω-3补充与自发性早产风险降低相关(RR 0.56,95%CI 0.36-0.87),非吸烟者中无此关联(RR 1.04,95%CI 0.84-1.29),交互作用P=0.013;低出生体重也仅在吸烟者中减少(RR 0.57,95%CI 0.36-0.90),交互作用P=0.047。

要点

  • 吸烟者中ω-3补充与复发性自发性早产风险降低相关(RR 0.56,95%CI 0.36-0.87)。
  • 非吸烟者中ω-3补充与自发性早产风险无显著关联(RR 1.04,95%CI 0.84-1.29)。
  • 吸烟者中ω-3补充与低出生体重减少相关(RR 0.57,95%CI 0.36-0.90),非吸烟者无显著关联(RR 0.93,95%CI 0.71-1.24)。

核心结论

  • 吸烟者中ω-3补充可能对复发性自发性早产和低出生体重具有保护作用。

研究设计与样本

  • 多中心随机对照试验的二次分析,纳入851例有单胎自发性早产史的单胎妊娠妇女,随机分为ω-3组或安慰剂组,于22周前开始补充直至分娩。
  • 所有妇女自孕16-20周起每周肌内注射17α-羟孕酮己酸酯,持续至孕36周或分娩(以先发生者为准)。

主要发现

  • 851例中136例(16%)吸烟;吸烟者与不吸烟者中ω-3组与安慰剂组基线特征无差异。
  • 吸烟者中ω-3补充与自发性早产风险降低相关(RR 0.56,95%CI 0.36-0.87),非吸烟者中无显著关联(RR 1.04,95%CI 0.84-1.29),交互作用P=0.013。
  • 吸烟者中ω-3补充与低出生体重风险降低相关(RR 0.57,95%CI 0.36-0.90),非吸烟者中无显著关联(RR 0.93,95%CI 0.71-1.24),交互作用P=0.047。
  • 其他次要结局在吸烟者与非吸烟者间的效应无显著差异。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Smoking during pregnancy is associated with adverse maternal and neonatal outcomes such as preterm delivery, intrauterine growth restriction, stillbirth, and low birth weight. Because smoking causes oxidative stress, some have suggested using antioxidants to counteract the effects of oxidative stress. Smokers have lower serum levels of omega-3 fatty acids, an important antioxidant, and thus, investigating whether omega-3 supplementation in smokers reduces adverse maternal and neonatal outcomes represents an important area of research. OBJECTIVE: To investigate whether the antioxidant effect of omega-3 fatty acid supplementation on the incidence of adverse pregnancy outcomes differs between smokers and nonsmokers. STUDY DESIGN: Secondary analysis of a multicenter randomized controlled trial of omega-3 supplementation for preterm delivery prevention in women with a singleton pregnancy and a history of a previous singleton spontaneous preterm delivery. Subjects were randomized to begin omega-3 or placebo before 22 weeks, which was continued until delivery. All women received 17 alpha-hydroxyprogesterone caproate intramuscularly weekly beginning between 16 and 20 weeks of gestation and continued until 36 weeks of gestation or delivery, whichever occurred first. The primary outcome was spontaneous preterm delivery. Secondary outcomes were indicated preterm delivery, any preterm delivery (spontaneous and indicated), pregnancy-associated hypertension (gestational hypertension and preeclampsia), a neonatal composite (retinopathy of prematurity, intraventricular hemorrhage grade III or IV, patent ductus arteriosus, necrotizing enterocolitis, sepsis, respiratory morbidity, or perinatal death), low birth weight (<2500 g), small for gestational age (less than the 10th percentile), and neonatal intensive care unit or intermediate nursery admission. The study population was stratified into smokers and nonsmokers, and the incidence of each outcome was compared by omega-3 supplementation versus placebo in each subgroup. Zelen tests were performed to test for homogeneity of effect in smokers and nonsmokers. RESULTS: Of 851 subjects included in the analysis, 136 (16%) smoked. Baseline characteristics between omega-3 and placebo groups did not differ in smokers or nonsmokers. Omega-3 supplementation was associated with a lower risk of spontaneous preterm delivery in smokers (relative risk, 0.56, 95% confidence interval, 0.36-0.87) but not in nonsmokers (relative risk 1.04, 95% confidence interval 0.84-1.29); P value for interaction = 0.013. Low birth weight was also less frequent in smokers receiving omega-3 supplementation (relative risk 0.57, 95% confidence interval 0.36-0.90) compared with nonsmokers (relative risk 0.93, 95% confidence interval 0.71-1.24); P value for interaction = 0.047. The effect on other secondary outcomes did not differ significantly between smokers and nonsmokers. CONCLUSION: Omega-3 supplementation in smokers may have a protective effect against recurrent spontaneous preterm delivery and low birth weight.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kuper SG, Abramovici AR, Jauk VC, et al. The effect of omega-3 supplementation on pregnancy outcomes by smoking status. Am J Obstet Gynecol. 2017. PMID: 28549983. doi:10.1016/j.ajog.2017.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。